(Q33284843)

25 July 2017

1 reference

title

A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? (English)

1 reference

Panteleimon Giannakopoulos

25 July 2017

1 reference

1 reference

5

object named as

Panteleimon Giannakopoulos

0 references

Eduard Vieta

object named as

Eduard Vieta

2

0 references

Hagop S. Akiskal

7

object named as

Hagop Akiskal

1 reference

25 July 2017

author name string

Konstantinos N Fountoulakis

1

1 reference

25 July 2017

Constantin Bouras

3

1 reference

25 July 2017

Grigorios Notaridis

4

1 reference

25 July 2017

George Kaprinis

6

1 reference

25 July 2017

publication date

17 May 2007

1 reference

The International Journal of Neuropsychopharmacology

25 July 2017

published in

1 reference

25 July 2017

volume

11

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

269-287

1 reference

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Long-term biphasic effects of lithium treatment on phospholipase C-coupled M3-muscarinic acetylcholine receptors in cultured cerebellar granule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium prevents colchicine-induced apoptosis in rat cerebellar granule neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Mood stabilizers, glycogen synthase kinase-3beta and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Anti-bipolar therapy: mechanism of action of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neuroprotective effect of ketamine administered after status epilepticus onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Treatment guidelines for bipolar disorder: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium encephalopathy: a clinical, psychiatric, and EEG evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

New data on lithium and haloperidol incompatibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium maintenance treatment of manic-melancholic patients: its role in the daily routine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

The full story of lithium. A tribute to Mogens Schou (1918-2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Is lithium able to reverse neurological damage induced by vinca alkaloids? (Short communication).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Ventricular dilation over several weeks following induction of excitotoxic (systemic lithium/pilocarpine) lesions: potential role of damage to the substantia nigra reticulata

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Abnormal expression of neuronal nitric oxide synthase triggers limbic seizures and hippocampal damage in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Soman-induced seizures: limbic activity, oxidative stress and neuroprotective proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Systemic administration of N omega-nitro-L-arginine methyl ester and indomethacin reduces the elevation of brain PGE2 content and prevents seizures and hippocampal damage evoked by LiCl and tacrine in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium-induced neurotoxicity at serum lithium levels within the therapeutic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Effect of neuroleptic drugs on lithium uptake by the human erythrocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Synergistic effects of tetrahydroaminoacridine and lithium on cholinergic function after excitotoxic basal forebrain lesions in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium toxicity: an iatrogenic problem in susceptible individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium alters brain activation in bipolar disorder in a task- and state-dependent manner: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Forty years of lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Emerging therapeutic targets in bipolar mood disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

The syndrome of irreversible lithium-effectuated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Tardive Parkinsonism, orofacial dyskinesia and akathisia following brief exposure to lithium carbonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Primary care use of antipsychotic drugs: an audit and intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Different dependence of lithium and valproate on PI3K/PKB pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Acute brain syndrome after tapering off clozapine in clozapine-lithium combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neurotoxicity associated with therapeutic serum lithium levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium ameliorates HIV-gp120-mediated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium and electrolytes plasma/RBC ratio and paradoxical lithium neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Does lithium therapy protect against the onset of dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neuroleptic malignant syndrome in 12 of 9,792 Chinese inpatients exposed to neuroleptics: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Ventricular enlargement and the lithium/pilocarpine seizure model: possible explanation for agonistic behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Effect of Li+ therapy and site of origin on cerebrospinal fluid beta-amyloid precursor protein derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

An investigation of the neuroprotective effect of lithium in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neuroprotective effects of lithium in cultured cells and animal models of diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium and calcium channel blockers: possible neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Stress-induced structural remodeling in hippocampus: prevention by lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Partial lithium-associated protection against apoptosis induced by C2-ceramide in cerebellar granule neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Chronic treatment with lithium increases the ecto-nucleotidase activities in rat hippocampal synatosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Selective regulation of presynaptic calcium/calmodulin-dependent protein kinase II by psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Nephrogenic diabetes insipidus in a lethargic lithium-treated patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Special considerations in the treatment of patients with bipolar disorder and medical co-morbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neuroplasticity and cellular resilience in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Linoleic acid in the treatment of lithium toxicity and familial tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Chronic lithium treatment with or without haloperidol fails to affect the morphology of the rat cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Effect of chronic lithium treatment with or without haloperidol on number and sizes of neurons in rat neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

The neuropathological effects of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium attenuates the development of lesion-induced behavioral supersensitivity to apomorphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Effective maintenance treatment--breaking the cycle of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Suicide risk in bipolar disorder during treatment with lithium and divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium neurotoxicity: the development of irreversible neurological impairment despite standard monitoring of serum lithium levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium and neuroleptics in combination: is there enhancement of neurotoxicity leading to permanent sequelae?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Abeta(1-42)-induced JNK and ERK activation in rabbit hippocampus is differentially regulated by lithium but is not involved in the phosphorylation of tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium inhibits aluminum-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Effects of lithium chloride on muricidal behavior in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium neuroprotection: molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Chronic lithium treatment inhibits pilocarpine-induced mossy fiber sprouting in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium treatment causes gliosis and modifies the morphology of hippocampal astrocytes in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium increases bcl-2 expression in chick cochlear nucleus and protects against deafferentation-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Prolonged low-dose caffeine exposure protects against hippocampal damage but not against the occurrence of epilepsy in the lithium-pilocarpine model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Optimal search strategies for identifying mental health content in MEDLINE: an analytic survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Paradoxical lithium neurotoxicity: a report of five cases and a hypothesis about risk for neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

beta-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

A case of lithium neurotoxicity with irreversible cerebellar syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Long-term lithium treatment prevents neurotoxic effects of beta-bungarotoxin in primary cultured neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium-induced delirium with therapeutic serum lithium levels: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Olanzapine-lithium encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Choreoathetosis: a sign of lithium toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Attenuation of N-methyl-D-aspartate-mediated cytoplasmic vacuolization in primary rat hippocampal neurons by mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Psychotic mania in glucose-6-phosphate-dehydrogenase-deficient subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neurotoxicity caused by lithium-verapamil synergism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Hippocampal volume measurement in older adults with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neurotoxicity with combined administration of lithium and a neuroleptic

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Neurotoxicity in patients with schizophrenia during lithium therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Elevation of RBC glycine and choline levels in geriatric patients treated with lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Hyperosmotic stress-induced apoptosis and tau phosphorylation in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

A case of lithium-induced asterixis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Molecular targets of lithium action

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

21 January 2018

Lithium encephalopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

Reversible lithium neurotoxicity at normal serum level may refer to intracranial pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Reversible neurotoxicity with combined lithium-haloperidol administration

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Calcium-dependent prevention of neuronal apoptosis by lithium ion: essential role of phosphoinositide 3-kinase and phospholipase Cgamma

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Lithium neurotoxicity.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Fever caused by lithium in a patient with neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Ageing as a risk factor for lithium neurotoxicity at therapeutic serum levels

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Effects of chronic lithium treatment on the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Fluoxetine treatment of social phobia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

A Creutzfeldt-Jakob like syndrome due to lithium toxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

On the pathogenesis of abnormal involuntary movements in lithium-treated patients with major affective disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Sixth cranial nerve palsy--unusual presenting symptom of lithium toxicity?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Incidence of delirium in older adults newly prescribed lithium or valproate: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Kinematics of fast wrist movements in manic-depressive illness chronically treated with lithium carbonate

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Lithium and memory: a review

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

The syndrome of irreversible lithium-effectuated neurotoxicity (SILENT).

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

EEG observations during combined haloperidol-lithium treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Lithium neurotoxicity at normal therapeutic levels

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Rapid induction of extrapyramidal side effects with combined use of lithium and neuroleptics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Predictors of tardive dyskinesia: results of a cross-sectional study in an outpatient population

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Preferential neuronal loss in layer III of the medial entorhinal cortex in rat models of temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Tardive dyskinesia in bipolar affective disorder: relationship to lithium therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Lithium and Suicidality Revisited

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Enhancement of hippocampal neurogenesis by lithium

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Subclinical lithium neurotoxicity: correlation of neural conduction abnormalities and serum lithium level in manic-depressive patients with lithium treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Electroencephalographic changes and other indices of neurotoxicity with haloperidol-lithium therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Normal spatial memory following postseizure treatment with ketamine: selective damage attenuates memory deficits in brain-damaged rodents

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Lithium-induced Creutzfeldt-Jakob syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Different mechanisms of protection against apoptosis by valproate and Li+

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Lithium-induced increase in human brain grey matter

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Prolonged neurological sequelae after combination treatment with lithium and antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

The effect of chronic lithium treatment on the calibre of axons and nerve fibres in the rat sural nerve

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Features of the comparative pharmacokinetics of lithium; a potential application of its use in livestock farming

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Tardive dyskinesia-like syndrome associated with lithium and carbamazepine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Characterization of inhibition by chronic treatment with lithium ion on nerve growth factor-induced neuronal differentiation of rat PC12 pheochromocytoma cells

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

The Wnt signaling pathway in bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

[Neurotoxic encephalopathy caused by neuroleptics and lithium]

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Neuroleptic malignant-like syndrome and lithium

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Creutzfeldt-Jakob-like syndrome induced by lithium, levomepromazine, and phenobarbitone

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Creutzfeld-Jacob like syndrome due to lithium toxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Acquired transient CNS hypersensitivity to lithium therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Encephalopathy with lithium and thioridazine in combination.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Chronic administration of lithium chloride increases immunodetectable glial fibrillary acidic protein in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Lithium intoxication: a report of two cases

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Reversible Creutzfeldt-Jakob like syndrome induced by lithium plus levodopa treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

A Creutzfeldt-Jakob like syndrome due to lithium toxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Lithium neurotoxicity at subtherapeutic serum levels

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Lithium neurotoxicity at normal therapeutic levels.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

Tardive dyskinesia reinduced by lithium carbonate

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007821

7 January 2021

10.1017/S1461145707007821

Identifiers

DOI

0 references

Fatcat ID

release_csawxlzvhfbplbj5kcrr3bu4gq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/csawxlzvhfbplbj5kcrr3bu4gq

24 November 2022

mapped directly with Wikidata item

1 reference